Tin tức & Cập nhật
Xem bài viết Thần kinh
Xem

AXS-05 delays relapse of Alzheimer's disease agitation
Treatment with AXS-05 significantly delayed the time to relapse of agitation in patients with Alzheimer’s disease (AD) compared with placebo, according to the phase III ACCORD-2 trial presented at AAN 2025.

Transnasal cooling a promising drug-free approach to tackling acute migraine attacks
An investigational neuromodulation device that delivers a controlled flow of dry, room-temperature air through the nasal passage helps relieve migraine pain, as shown in a study.

Tolebrutinib reduces disability accumulation in relapsing MS
Treatment with tolebrutinib results in a clear reduction in disability accumulation in patients with relapsing multiple sclerosis (MS) compared with teriflunomide despite no difference in relapses, according to the findings of the GEMINI 1 and 2 trials presented at AAN 2025.

Consistent benefits with lecanemab seen in Clarity AD Asian cohort
In the treatment of early Alzheimer’s disease (AD), lecanemab is as safe and efficacious in Asian patients as in the wider Clarity AD population, slowing cognitive decline and reducing amyloid levels in the brain with manageable risks.




